Abstract
IgA nephropathy (IgAN) is one of the most common recurrent glomerulonephritis after renal transplantation. Rarely, it is accompanied with the presence of crescents that leads to rapid deterioration of renal function and graft loss. We present a 54-year-old patient with IgAN that received a cadaveric kidney allograft, but developed biopsy proven recurrent IgAN 7 months after renal transplantation. He was treated with intravenous steroids and angiotensin-converting enzyme inhibitor and remission was achieved. 4 years later, he presented again with heavy proteinuria, hematuria and deterioration of renal function. Allograft biopsy revealed recurrent IgAN with crescents, which was successfully treated with pulse intravenous steroids and six monthly doses of intravenous cyclophosphamide. This regime resulted in long-term sustained remission with a stable functioning graft 3 years later. Although it is not an established treatment as in native kidneys, intravenous cyclophosphamide should probably be considered in kidney transplants with potentially reversible recurrent crescentic IgAN.
Similar content being viewed by others
References
Wyatt RJ, Julian BA. IgA nephropathy. N Engl J Med. 2013;368(25):2402–14. https://doi.org/10.1056/NEJMra1206793.
D’Amico G. Natural history of idiopathic IgA nephropathy and factors predictive of disease outcome. Semin Nephrol. 2004;24(3):179 – 96.
Floege J. Recurrent IgA nephropathy after renal transplantation. Semin Nephrol. 2004;24(3):287 – 91.
Ponticelli C, Glassock RJ. Posttransplant recurrence of primary glomerulonephritis. Clin J Ame Soc Nephrol. 2010;5(12):2363–72. https://doi.org/10.2215/cjn.06720810.
Cosio FG, Cattran DC. Recent advances in our understanding of recurrent primary glomerulonephritis after kidney transplantation. Kidney Int. 2017;91(2):304 – 14. https://doi.org/10.1016/j.kint.2016.08.030.
Allen PJ, Chadban SJ, Craig JC, Lim WH, Allen RDM, Clayton PA, et al. Recurrent glomerulonephritis after kidney transplantation: risk factors and allograft outcomes. Kidney Int. 2017;92(2):461–9. https://doi.org/10.1016/j.kint.2017.03.015.
Kowalewska J, Yuan S, Sustento-Reodica N, Nicosia RF, Smith KD, Davis CL, et al. IgA nephropathy with crescents in kidney transplant recipients. Am J Kidney Dis. 2005;45(1):167 – 75.
Jennette JC. Rapidly progressive crescentic glomerulonephritis. Kidney Int. 2003;63(3):1164–77. https://doi.org/10.1046/j.1523-1755.2003.00843.x.
Jeong HJ, Kim YS, Kwon KH, Kim SI, Kim MS, Choi KH, et al. Glomerular crescents are responsible for chronic graft dysfunction in post-transplant IgA nephropathy. Pathol Int. 2004;54(11):837–842. https://doi.org/10.1111/j.1440-1827.2004.01751.x.
Tang Z, Ji SM, Chen DR, Wen JQ, Chen JS, Liu ZH, et al. Recurrent or de novo IgA nephropathy with crescent formation after renal transplantation. Renal Fail. 2008;30(6):611–6. https://doi.org/10.1080/08860220802134516.
Diaz-Tejeiro R, Maduell F, Diez J, Esparza N, Errasti P, Purroy A, et al. Loss of renal graft due to recurrent IgA nephropathy with rapidly progressive course: an unusual clinical evolution. Nephron. 1990;54(4):341–3.
Robles NR, Gomez Campdera FJ, Anaya F, Niembro De Rasche E, Galan A, Rengel MA, et al. IgA nephropathy with rapidly progressive course after kidney transplantation. Nephron. 1991;58(4):487–8.
Streather CP, Scoble JE. Recurrent IgA nephropathy in a renal allograft presenting as crescentic glomerulonephritis. Nephron. 1994;66(1):113–4.
Park SB, Joo I, Park KA, Cho WH, Park CH, Kim SP, et al. Rapidly progressive glomerulonephritis in a renal transplant with recurrent IgA nephropathy. Transpl Proc. 1996;28(3):1529–30.
Shimizu T, Tanabe K, Tokumoto T, Shimmura H, Koga S, Ishikawa N, et al. A case of rapid progressive glomerulonephritis with IgA deposits after renal transplantation. Clin Transpl. 2001;15(5):11–5.
Benabdallah L, Rerolle JP, Peraldi MN, Noel LH, Bruneel MF, Carron PL, et al. An unusual recurrence of crescentic nephritis after renal transplantation for IgA nephropathy. Am J Kidney Dis. 2002;40(6):E20. https://doi.org/10.1053/ajkd.2002.36931.
Mousson C, Charon-Barra C, Funes de la Vega M, Tanter Y, Justrabo E, Martin L, et al. Recurrence of IgA nephropathy with crescents in kidney transplants. Transpl Proc. 2007;39(8):2595–6. https://doi.org/10.1016/j.transproceed.2007.08.025.
Gopalakrishnan N, Murugananth S, Dineshkumar T, Dhanapriya J, Sakthirajan R, Balasubramaniyan T. Two consecutive recurrences of crescentic immunoglobulin a nephropathy in a renal transplant recipient. Indian J Nephrol. 2016;26(5):376–8. https://doi.org/10.4103/0971-4065.169565.
Herzog AL, Wanner C, Amann K, Lopau K. First treatment of relapsing rapidly progressive IgA nephropathy With Eculizumab after living kidney donation: a case report. Transpl Proc. 2017;49(7):1574–7. https://doi.org/10.1016/j.transproceed.2017.02.044.
Katsumata H, Yamamoto I, Komatsuzaki Y, Kawabe M, Okabayashi Y, Yamakawa T, et al. Successful treatment of recurrent immunoglobulin a nephropathy using steroid pulse therapy plus tonsillectomy 10 years after kidney transplantation: a case presentation. BMC Nephrol. 2018;19(1):64. https://doi.org/10.1186/s12882-018-0858-9.
Radhakrishnan J, Cattran DC. The KDIGO practice guideline on glomerulonephritis: reading between the (guide) lines–application to the individual patient. Kidney Int. 2012;82(8):840–56. https://doi.org/10.1038/ki.2012.280.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors have declared that no Conflict of interest exists.
Research involving human participants and/or animals
This article does not contain any studies with human participants or animals performed by any of the authors.
Informed Consent
Informed consent was obtained from all individual participants included in the study. Additional informed consent was obtained from all individual participants for whom identifying information is included in this article.
About this article
Cite this article
Zagkotsis, G., Vourlakou, C., Paraskevopoulos, A. et al. Recurrence of crescentic IgA nephropathy after renal transplantation. CEN Case Rep 7, 268–273 (2018). https://doi.org/10.1007/s13730-018-0341-2
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s13730-018-0341-2